CRISPR-empowered electrochemical biosensor for target amplification-free and sensitive detection of miRNA.
CRISPR-empowered electrochemical biosensor for target amplification-free and sensitive detection of miRNA.
复制标题
DOI:
10.1016/j.talanta.2023.125125
复制
发表时间:
2023-08
期刊:
影响因子:
6.1
通讯作者:
Chihong Ma;Qin Zhou;Jinjin Shi;Hua Gao;Di Huang;Huimin Xue;Han Wang;Zhenzhong Zhang;Sen Yang;Junli Zhang;Kaixiang Zhang
中科院分区:
文献类型:
--
作者:
Chihong Ma;Qin Zhou;Jinjin Shi;Hua Gao;Di Huang;Huimin Xue;Han Wang;Zhenzhong Zhang;Sen Yang;Junli Zhang;Kaixiang Zhang
The clustered regularly interspaced short palindromic repeats (CRISPR) system provides a new molecular diagnostic tool for construction of biosensor platforms due to its high programmability and target specificity. Herein, we developed a CRISPR-empowered electrochemical biosensor by combining the advantages of CRISPR/Cas13a and primer exchange reaction (PER), named PER-E-CRISPR, for target amplification-free and sensitive detection of miR-21. Dual-signal amplification procedures involve the binding of target miR-21 induced by CRISPR-based amplification, along with the hybridization of multiple short single-stranded DNA strands with PER concatemers. When target miR-21 is present, CRISPR/Cas13a specifically recognizes the target miRNA, triggering thetrans-cleavage activity of CRISPR/Cas13a. Then Cas13a/crRNA/miRNA cleaved the predesigned ribonucleotide site in hairpin 1 (HP1) and released trigger to open hairpin 2 (HP2) modified on the electrode surface. Then PER bridge sequence contained in HP2 is exposed and hybridized with PER concatemers, following multiple short single-stranded DNA tagged with methylene blue (ssDNA-MB) bond with the PER concatemers. Under optimized conditions, PER-E-CRISPR assay for detecting miR-21 exhibits linearity in dynamic range from 10−13to 10−7M, and we obtained a limit of detection (LOD) of 30.2 fM. The established PER-E-CRISPR biosensor shows perfect practical performance in actual plasma, which may have great promising prospects for miRNA detection in the field of molecular diagnosis.